Li Ying, Srinath Abhinav, Alcazar-Felix Roberto J, Hage Stephanie, Bindal Akash, Lightle Rhonda, Shenkar Robert, Shi Changbin, Girard Romuald, Awad Issam A
Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Neurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, Chicago, IL 60637, USA.
Brain Sci. 2023 Sep 17;13(9):1336. doi: 10.3390/brainsci13091336.
Cerebral cavernous malformation (CCM) is a common cerebrovascular malformation causing intracranial hemorrhage, seizures, and focal neurologic deficits. A unique CCM lesional inflammatory microenvironment has been shown to influence the clinical course of the disease. This review addresses the inflammatory cell infiltrate in the CCM lesion and the role of a defined antigen-driven immune response in pathogenicity. We summarize immune mechanisms associated with the loss of the CCM gene and disease progression, including the potential role of immunothrombosis. We also review evidence of circulating inflammatory biomarkers associated with CCM disease and its clinical activity. We articulate future directions for this research, including the role of individual cell type contributions to the immune response in CCM, single cell transcriptomics of inflammatory cells, biomarker development, and therapeutic implications. The concepts are applicable for developing diagnostic and treatment strategies for CCM and for studying other neurovascular diseases.
脑海绵状血管畸形(CCM)是一种常见的脑血管畸形,可导致颅内出血、癫痫发作和局灶性神经功能缺损。已证明独特的CCM病变炎性微环境会影响该疾病的临床病程。本文综述了CCM病变中的炎性细胞浸润以及特定抗原驱动的免疫反应在发病机制中的作用。我们总结了与CCM基因缺失和疾病进展相关的免疫机制,包括免疫血栓形成的潜在作用。我们还综述了与CCM疾病及其临床活动相关的循环炎性生物标志物的证据。我们阐述了该研究的未来方向,包括个体细胞类型对CCM免疫反应的贡献、炎性细胞的单细胞转录组学、生物标志物开发以及治疗意义。这些概念适用于制定CCM的诊断和治疗策略以及研究其他神经血管疾病。